ResearchAndMarkets.com released a comprehensive report analyzing over 1,230 bioinformatics collaboration and licensing deals from 2019 to 2026. The report offers detailed insights into deal structures, including upfront payments, milestones, royalties, and contract terms, helping companies benchmark transactions and negotiate partnerships effectively. It highlights how data, algorithms, and technology platforms drive dealmaking in bioinformatics, providing transparency on rights, responsibilities, and financial arrangements. This resource supports strategic decision-making and valuation in a data-driven biotech market.
10x Genomics, a leader in life science technology, will announce its financial results for Q2 ended June 30, 2026, after market close on August 6, 2026. The company will hold a public conference call and live webcast at 1:30 p.m. PT to discuss its ea...
Torex Gold Resources announced positive drilling outcomes at its Morelos Complex, including the ELG Underground and Media Luna Cluster, indicating potential for significant resource expansion and extended mine life. High-grade mineralization was enco...
